hl7-eu-logo
PROTECT-CHILD Pediatric Transplant Data Implementation Guide
0.1.0-ci-build -

PROTECT-CHILD Pediatric Transplant Data Implementation Guide
0.1.0-ci-build - ci-build

PROTECT-CHILD Pediatric Transplant Data Implementation Guide, published by Protect Child. This guide is not an authorized publication; it is the continuous build for version 0.1.0-ci-build built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/protect-child/ and changes regularly. See the Directory of published versions

Table of Contents

.. 0 Table of Contents
... 1 Home
... 2 Logical Models
... 3 Data Model (ERD)
... 4 Model Maps
.... 4.1 Patient
.... 4.2 Donor
.... 4.3 Visit
.... 4.4 Transplant
.... 4.5 Immunological Data
.... 4.6 Vital Sign
.... 4.7 BioSample
.... 4.8 Pre-Medication
.... 4.9 Clinical Variable
.... 4.10 Concomitant Medication
.... 4.11 Microbiology
.... 4.12 Instrumental Investigation
.... 4.13 Immunosuppressant
.... 4.14 Laboratory
.... 4.15 Clinical Event Type
.... 4.16 Clinical Event
... 5 Artifacts Summary
.... 5.1 BioSample logical model
.... 5.2 ClinicalEvent logical model
.... 5.3 ClinicalEventType logical model
.... 5.4 ClinicalVariable logical model
.... 5.5 ConcomitantMedication logical model
.... 5.6 Donor logical model
.... 5.7 ImmPat logical model
.... 5.8 Immunological Data logical model
.... 5.9 Immunosuppressant logical model
.... 5.10 InstrumentalInvestigation logical model
.... 5.11 LabResult logical model
.... 5.12 LabTest logical model
.... 5.13 Microbiology logical model
.... 5.14 Patient logical model
.... 5.15 PreMedication logical model
.... 5.16 Transplant logical model
.... 5.17 Visit logical model
.... 5.18 Vital Sign logical model
.... 5.19 Biological Sample
.... 5.20 Biological Sample Analysis Request
.... 5.21 Clinical Event
.... 5.22 Clinical Event Flag Observation
.... 5.23 Clinical Event Procedure
.... 5.24 Clinical Variable
.... 5.25 Concomitant Medication
.... 5.26 Donor liver graft type observation
.... 5.27 Donor pre-KTX dialysis type observation
.... 5.28 Immunological Data
.... 5.29 Immunosuppressant
.... 5.30 Immunosuppressant PK Observation
.... 5.31 Immunosuppressant to Patient
.... 5.32 Instrumental Investigation
.... 5.33 Lab Result
.... 5.34 Lab Test
.... 5.35 Laboratory DiagnosticReport
.... 5.36 Microbiology
.... 5.37 Patient Demographics Observation
.... 5.38 Patient Instrumental Investigation
.... 5.39 Patient Liver Disease Diagnosis
.... 5.40 Patient Pre-transplant Immunology Observation
.... 5.41 Patient Renal Disease Diagnosis
.... 5.42 Pre-transplant Medication
.... 5.43 Pre-transplant Medication — Child Record
.... 5.44 Study Centre
.... 5.45 Transplant
.... 5.46 Transplant Details
.... 5.47 Transplant Donor
.... 5.48 Transplant Recipient
.... 5.49 Visit
.... 5.50 Vital Sign
.... 5.51 Transplant donor reference
.... 5.52 Transplant type context
.... 5.53 Visit reference
.... 5.54 ABO Group ValueSet
.... 5.55 Banff Category ValueSet
.... 5.56 Biological Sample Analysis Type ValueSet
.... 5.57 Clinical Event Flag ValueSet
.... 5.58 Clinical Event Procedure Type ValueSet
.... 5.59 Clinical Event Type ValueSet
.... 5.60 Concomitant Disease Category ValueSet
.... 5.61 Dialysis method ValueSet
.... 5.62 Donor Liver Type ValueSet
.... 5.63 DSA HLA Class ValueSet
.... 5.64 Immunosuppressant Dose Unit ValueSet
.... 5.65 Immunosuppressant Drug Type
.... 5.66 Immunosuppressant Phase ValueSet
.... 5.67 Immunosuppressant PK Observation Type ValueSet
.... 5.68 Instrumental Investigation Name
.... 5.69 Intraoperative Complications ValueSet
.... 5.70 Lab Result Unit ValueSet
.... 5.71 Lab Test Name ValueSet
.... 5.72 MFI Category ValueSet
.... 5.73 Patient Instrumental Investigation Result ValueSet
.... 5.74 PRA Type ValueSet
.... 5.75 Pre-medication Antihypertensive Drug ValueSet
.... 5.76 Rh Factor ValueSet
.... 5.77 Transplant Detail ValueSet
.... 5.78 Transplant Type ValueSet
.... 5.79 Type of surgical biliary anastomosis ValueSet
.... 5.80 Ureteral Graft Anastomosis Type ValueSet
.... 5.81 Vascular Complication Type ValueSet
.... 5.82 Visit Type ValueSet
.... 5.83 ABO Group CodeSystem
.... 5.84 Banff Category CodeSystem
.... 5.85 Biological Sample Analysis Type
.... 5.86 Clinical Event Evidence CodeSystem
.... 5.87 Clinical Event Procedure Type CodeSystem
.... 5.88 Clinical Event Type CodeSystem
.... 5.89 Clinical Variable Component Codes
.... 5.90 Concomitant Disease Category CodeSystem
.... 5.91 Donor Liver Type CodeSystem
.... 5.92 DSA HLA Class CodeSystem
.... 5.93 Immunological Data Component Codes
.... 5.94 Immunological Data Panel CodeSystem
.... 5.95 Immunosuppressant Drug Type
.... 5.96 Immunosuppressant Phase CodeSystem
.... 5.97 Immunosuppressant PK Observation Type CodeSystem
.... 5.98 Instrumental Investigation Name
.... 5.99 Intraoperative Complications CodeSystem
.... 5.100 Lab Test Local Codes
.... 5.101 MFI Category CodeSystem
.... 5.102 Microbiology component codes
.... 5.103 Patient Instrumental Investigation Result CodeSystem
.... 5.104 Patient Observations Panel CodeSystem
.... 5.105 PRA Type CodeSystem
.... 5.106 Pre-medication Antihypertensive Drug CodeSystem
.... 5.107 Rh Factor CodeSystem
.... 5.108 Transplant Detail CodeSystem
.... 5.109 Transplant Type CodeSystem
.... 5.110 Type of surgical biliary anastomosis CodeSystem
.... 5.111 Ureteral Graft Anastomosis Type CodeSystem
.... 5.112 Vascular Complication Type CodeSystem
.... 5.113 Visit Type CodeSystem
.... 5.114 Vital Sign Local Codes
.... 5.115 Study centre identifier namespace
.... 5.116 Example Biological Sample
.... 5.117 Example Clinical Event Procedure — Hemodialysis
.... 5.118 Example Clinical Event Procedure — Retransplantation
.... 5.119 Example Clinical Event Procedure — Transplant List Entry
.... 5.120 Example Clinical Event — Kidney Rejection START
.... 5.121 Example Clinical Variable
.... 5.122 Example Concomitant Medication
.... 5.123 Example donor age observation
.... 5.124 Example donor liver graft type
.... 5.125 Example donor pre-KTX dialysis type
.... 5.126 Example genomic analysis request
.... 5.127 Example ImmPat PK Observation — Pre-dose level
.... 5.128 Example Immunological Data
.... 5.129 Example Immunosuppressant
.... 5.130 Example Immunosuppressant to Patient — Induction
.... 5.131 Example Immunosuppressant to Patient — Maintenance
.... 5.132 Example Instrumental Investigation
.... 5.133 Example Lab Result Observation
.... 5.134 Example Lab Test
.... 5.135 Example Laboratory Report
.... 5.136 Example Microbiology record
.... 5.137 Example patient age observation
.... 5.138 Example Patient Instrumental Investigation
.... 5.139 Example patient liver disease diagnosis
.... 5.140 Example patient pre-transplant immunology observation
.... 5.141 Example patient renal disease diagnosis
.... 5.142 Example Pre-medication
.... 5.143 Example transplant
.... 5.144 Example Transplant Details
.... 5.145 Example transplant donor
.... 5.146 Example transplant recipient
.... 5.147 Example visit
.... 5.148 Example Vital Sign
.... 5.149 PROTECT-CHILD Centre 1 — La Paz
.... 5.150 PROTECT-CHILD Centre 2 — Padova
.... 5.151 PROTECT-CHILD Centre 3 — Palma
.... 5.152 PROTECT-CHILD Centre 4 — Hamburg